Your browser doesn't support javascript.
loading
GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry.
Hartmann, Jessica; Thalheimer, Frederic B; Höpfner, Felix; Kerzel, Thomas; Khodosevich, Konstantin; García-González, Diego; Monyer, Hannah; Diester, Ilka; Büning, Hildegard; Carette, Jan E; Fries, Pascal; Buchholz, Christian J.
Afiliación
  • Hartmann J; Division of Medical Biotechnology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
  • Thalheimer FB; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.
  • Höpfner F; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.
  • Kerzel T; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.
  • Khodosevich K; Biotech Research and Innovation Centre (BRIC), Faculty of Health, University of Copenhagen, Copenhagen, Denmark.
  • García-González D; Department of Clinical Neurobiology, Medical Faculty of Heidelberg University and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Monyer H; Department of Clinical Neurobiology, Medical Faculty of Heidelberg University and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Diester I; Optophysiology Lab, Institute of Biology III, BrainLinks-BrainTools, Bernstein Center Freiburg, University of Freiburg, 79104 Freiburg, Germany.
  • Büning H; Laboratory for Infection Biology & Gene Transfer, Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Carette JE; Department of Microbiology and Immunology, Stanford University School of Medicine, 94305 Stanford, CA, USA.
  • Fries P; Ernst-Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max-Planck Society, 60528 Frankfurt, Germany.
  • Buchholz CJ; Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 Nijmegen, the Netherlands.
Mol Ther Methods Clin Dev ; 14: 252-260, 2019 Sep 13.
Article en En | MEDLINE | ID: mdl-31463334
ABSTRACT
Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2019 Tipo del documento: Article País de afiliación: Alemania